Jeffrey Tyner
Overview
Explore the profile of Jeffrey Tyner including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
1136
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Oyogoa E, Traer E, Tyner J, Lachowiez C
Cancers (Basel)
. 2023 Jul;
15(14).
PMID: 37509251
Frontline acute myeloid leukemia (AML) treatment is determined by a combination of patient and genetic factors. This includes patient fitness (i.e., comorbidities that increase the risk of treatment-related mortality) and...
2.
Diamond B, Ziccheddu B, Maclachlan K, Taylor J, Boyle E, Arango Ossa J, et al.
Blood
. 2023 Jan;
141(19):2359-2371.
PMID: 36626250
Patients treated with cytotoxic therapies, including autologous stem cell transplantation, are at risk for developing therapy-related myeloid neoplasms (tMN). Preleukemic clones (ie, clonal hematopoiesis [CH]) are detectable years before the...
3.
Gosline S, Tognon C, Nestor M, Joshi S, Modak R, Damnernsawad A, et al.
Clin Proteomics
. 2022 Jul;
19(1):30.
PMID: 35896960
Acute Myeloid Leukemia (AML) affects 20,000 patients in the US annually with a five-year survival rate of approximately 25%. One reason for the low survival rate is the high prevalence...
4.
Khoury J, Solary E, Abla O, Akkari Y, Alaggio R, Apperley J, et al.
Leukemia
. 2022 Jun;
36(7):1703-1719.
PMID: 35732831
The upcoming 5th edition of the World Health Organization (WHO) Classification of Haematolymphoid Tumours is part of an effort to hierarchically catalogue human cancers arising in various organ systems within...
5.
Rozanov D, Cheltsov A, Nilsen A, Boniface C, Forquer I, Korkola J, et al.
PLoS One
. 2019 Mar;
14(3):e0205623.
PMID: 30908483
To determine the target of the recently identified lead compound NSC130362 that is responsible for its selective anti-cancer efficacy and safety in normal cells, structure-activity relationship (SAR) studies were conducted....
6.
Borate U, Norris B, Lo P, Tognon C, Tyner J, Spurgeon S
Am J Hematol
. 2017 Feb;
92(5):E64-E66.
PMID: 28181280
No abstract available.
7.
Stevens B, Maxson J, Tyner J, Smith C, Gutman J, Robinson W, et al.
Leuk Lymphoma
. 2015 Sep;
57(4):927-34.
PMID: 26389776
A rare but well-known association between plasma cell neoplasms and neutrophilia is known to exist. Whether the neutrophilia is secondary to the plasma cell neoplasm or this convergence represents two...
8.
Huang T, Cutler J, Bharne S, Zhong J, Weinstock D, Tyner J, et al.
Leuk Lymphoma
. 2014 Sep;
56(5):1524-7.
PMID: 25213184
No abstract available.
9.
Dewey T, Bowers B, Thourani V, Babaliaros V, Smith C, Leon M, et al.
Ann Thorac Surg
. 2013 Aug;
96(6):2083-9.
PMID: 23968764
Background: Transapical (TA) aortic valve replacement was an integral part of the Placement of Transcatheter Aortic Valves (PARTNER) trial. Enrollment during the randomized trial included 104 transapical (premarket approval TA...
10.
van Bodegom D, Zhong J, Kopp N, Dutta C, Kim M, Bird L, et al.
Blood
. 2012 Aug;
120(14):2853-63.
PMID: 22915648
Approximately 10% of B-cell acute lymphoblastic leukemias (B-ALLs) overexpress the cytokine receptor subunit CRLF2, which may confer a poor prognosis. CRLF2 binds its ligand thymic stromal lymphopoietin (TSLP) as a...